论文部分内容阅读
Beakkeskov等证明谷氨酸脱羧酶(GDC)是1型糖尿病的关键始动靶抗原,在1型糖尿病患者血清中有较高水平的谷氨酸脱羧酶抗体(GDC-Ab)存在。本文报道88例糖尿病患者血清中GDC-Ab的测定结果。材料和方法一、受检对象 1.对照组 32名无糖尿病史及其他内分泌疾病史的健康人。2.糖尿病
Beakkeskov et al. Demonstrated that glutamate decarboxylase (GDC) is a key initiating target antigen for type 1 diabetes and that a higher level of glutamic acid decarboxylase antibody (GDC-Ab) is present in the serum of type 1 diabetic patients. This article reports 88 cases of diabetes serum GDC-Ab assay results. Materials and methods First, subjects 1. Control group of 32 non-diabetic and other endocrine disease history of healthy people. Diabetes